These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12107372)

  • 1. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings.
    Marette A
    Curr Opin Clin Nutr Metab Care; 2002 Jul; 5(4):377-83. PubMed ID: 12107372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory pathways and insulin action.
    Hotamisligil GS
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S53-5. PubMed ID: 14704746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Obesity, diabetes and insulin resistance. Alterations of insulin signalling].
    Le Marchand-Brustel Y; Gual P; Aouadi M; Grémeaux T; Binétruy B; Bost F; Tanti JF
    J Soc Biol; 2006; 200(1):93-7. PubMed ID: 17144167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice.
    Chen WY; Chen CJ; Liu CH; Mao FC
    Diabetes Obes Metab; 2009 Apr; 11(4):293-303. PubMed ID: 18721257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species.
    Wei Y; Chen K; Whaley-Connell AT; Stump CS; Ibdah JA; Sowers JR
    Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R673-80. PubMed ID: 18094066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of obesity and diabetes: at the intersection of weight regulation, inflammation, and glucose homeostasis.
    O'Rourke RW
    World J Surg; 2009 Oct; 33(10):2007-13. PubMed ID: 19424747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists.
    Fernández-Veledo S; Vila-Bedmar R; Nieto-Vazquez I; Lorenzo M
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3583-93. PubMed ID: 19567513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice.
    Shao J; Yamashita H; Qiao L; Friedman JE
    J Endocrinol; 2000 Oct; 167(1):107-15. PubMed ID: 11018758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin resistance and nitric oxide: molecular mechanisms and pathophysiological associations].
    Tousková V; Haluzík M
    Cesk Fysiol; 2011; 60(2):40-7. PubMed ID: 22263324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals.
    Kim MS; Lee MS; Kown DY
    Ann N Y Acad Sci; 2011 Jul; 1229():140-6. PubMed ID: 21793849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, inflammation, and insulin resistance--a mini-review.
    Zeyda M; Stulnig TM
    Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory status and insulin resistance.
    Grimble RF
    Curr Opin Clin Nutr Metab Care; 2002 Sep; 5(5):551-9. PubMed ID: 12172480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism, treatment, and evaluation of obesity-induced insulin resistance and type 2 diabetes].
    Zhao WG; Zhu HJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):7-12. PubMed ID: 20236579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction.
    Khodabandehloo H; Gorgani-Firuzjaee S; Panahi G; Meshkani R
    Transl Res; 2016 Jan; 167(1):228-56. PubMed ID: 26408801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway.
    Liu K; Luo T; Zhang Z; Wang T; Kou J; Liu B; Huang F
    J Ethnopharmacol; 2011 Jul; 136(3):473-9. PubMed ID: 21296137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance.
    Zick Y
    Sci STKE; 2005 Jan; 2005(268):pe4. PubMed ID: 15671481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation.
    Tanti JF; Jager J
    Curr Opin Pharmacol; 2009 Dec; 9(6):753-62. PubMed ID: 19683471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Elucidation of a New Mechanism of Onset of Insulin Resistance: Effects of Statins and Tumor Necrosis Factor-α on Insulin Signal Transduction].
    Takaguri A
    Yakugaku Zasshi; 2018; 138(11):1329-1334. PubMed ID: 30381640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.